SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | +1100.0% | 30,697 | +1299.8% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 2,193 | -25.1% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 2,929 | +33.6% | 0.00% | – |
| Q4 2021 | $10,000 | -58.3% | 2,193 | -29.3% | 0.00% | – |
| Q3 2021 | $24,000 | -20.0% | 3,100 | 0.0% | 0.00% | – |
| Q2 2021 | $30,000 | +57.9% | 3,100 | +36.5% | 0.00% | – |
| Q1 2021 | $19,000 | -66.7% | 2,271 | -72.6% | 0.00% | -100.0% |
| Q4 2020 | $57,000 | -18.6% | 8,287 | +26.8% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | +536.4% | 6,537 | +296.2% | 0.00% | – |
| Q2 2020 | $11,000 | +175.0% | 1,650 | -17.5% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |